Brief: Avid Bioservices Q3 revenue USD 38 million
13/03/2023 20:11
Mar 13 (Reuters) - Avid Bioservices Outlook FY revenue USD 145-150 million. * Q3 net income USD 500 thousand * Q3 revenue USD 38 million * Q3 gross margin 26% * Q3 orders USD 176 million
Recent news on Avid Bioservices
See all newsBrief: Avid Bioservices Recommends Stockholders Vote For Value Maximizing Transaction
Avid Bioservices Inc reports results for the quarter ended October 31 - Earnings Summary
U.S. RESEARCH ROUNDUP- Autozone, Costco Wholesale, Salesforce
Press Digest: Wall Street Journal - Nov. 7
Brief: Avid Bioservices to be acquired for $1.1 bln by GHO Capital Partners, Ampersand Capital Partners